The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells

European Journal of Pharmacology

Volumn 336, Issue 2-3, 1997, Pages 243-249

  Rundfeldt, Chris ^a  

^a Arzneimittelwerk Dresden GmbH   (Germany)

Author keywords

Antiepileptics; Cortical neurons; Cromakalim; Glibencalmide; HNT neurons; Membrane potential; Mouse; NG 108 15 cells; Patch clamp electrophysiology

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; POTASSIUM CHANNEL; RETIGABINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; ARTICLE; CELL CULTURE; CELL LINE; CHANNEL GATING; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; NERVE CELL; PATCH CLAMP; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; CARBAMATES; HUMANS; MICE; NEURONS; PATCH-CLAMP TECHNIQUES; PHENYLENEDIAMINES; POTASSIUM CHANNELS; RATS; TUMOR CELLS, CULTURED;

EID: 0030668611     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01249-1     Document Type: Article

References (31)

1. Alzheimer C., Ten Bruggencate G. Actions of BRL 34915 (Cromakalim) upon convulsive discharges in guinea pig hippocampal slices. Arch. Pharmacol. 337:1988;429-434.
2. Bernardi, H., Lazdunski, M., 1993. Characterization of the sulfonylurea-sensitive ATP-modulated potassium channel. In: Glossmann, H., Striessnig, J. (Eds.), Molecular and Cellular Biology of Pharmacological Targets. Plenum Press, New York.
3. Bodewei R., Hering S., Schubert B., Wollenberger A. Sodium and calcium currents in neuroblastome×glioma hybrid cells before and after morphological differentiation by dibutyryl cyclic AMP. Gen. Physiol. Biophys. 4:1985;113-127.
4. Colatsky T.J., Follmer C.H., Starmer C.F. Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmiasis. Circulation. 82:1990;2235-2242.
5. Del Pozo E., Barrios M., Baeyens J.M. Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice. Pharmacol. Toxicol. 67:1990;182-184.
6. Doupnik C.A., Davidson N., Lester H.A. The inward rectifier potassium channel family. Curr. Opin. Neurobiol. 5:1995;268-277.
7. Edwards G., Weston A.H. The pharmacology of ATP-sensitive potassium channels. Annual Rev. Pharmacol. Toxicol. 33:1993;597-637.
8. Goldstein S.A.N., Price L.A., Rosenthal D.N., Pausch M.H. ORK 1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 93:1996;13256-13261.
9. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch. 391:1981;85-100.
10. Hille, B., 1993. Ionic Channels of Excitable Membranes, 2nd ed. Sinauer, Sunderland, MA.
11. Jainta H., Tober C., Kronbach T. Exploratory pharmacokinetics of the new anticonvulsant D-23129 in rats and dogs investigated by column-switching HPLC. Naunyn-Schmiedenbergs Arch. Pharmacol. 351 (Suppl.):1995;R51.
12. Kapetanovic I.M., Rundfeldt C. D-23129: A new anticonvulsant compound. CNS Drug Rev. 2:1996;308-321.
13. Kapetanovic I.M., Yonekawa W.D., Kupferberg H.J. The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro. Epilepsy Res. 22:1995;167-173.
14. Kubo Y., Baldwin T.J., Jan Y.N., Jan L.Y. Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature. 362:1993;127-133.
15. Lee V., McGrogan M., Lernhardt W., Huvar A. hNT Neurons: Human postmitotic CNS neurons. Strategies. 7:1994;28-31.
16. + channel with a novel structure. EMBO J. 15:1996;1004-1011.
17. McKay M.C., Dworetzky S.I., Meanwell N.A., Olesen S.-P., Reinhart R.H., Levitan I.B., Adelman J.P., Gribkoff V.K. Opening of large-conductance calcium-activated potassium channels by the substituted benzimidazolone NS004. J. Neurophysiol. 71:1994;1873-1882.
18. Pleasure S.J., Page C., Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1992;1802-1815.
19. Popoli P., Pezzola A., Sagratella S., Zeng Y.C., Scotti de Carolis A. Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats. Br. J. Pharmacol. 104:1991;907-913.
20. Rostock A., Tober C., Rundfeldt C., Bartsch R., Engel J., Polymeropoulos E.E., Kutscher B., Löscher W., Hönack D., White H.S., Wolf H.H. D-23129: A new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 23:1996;211-223.
21. Rogawski M.A., Porter R.J. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-286.
22. Rudy B. Diversity and ubiquity of potassium channels. Neuroscience. 25:1988;729-749.
23. Rundfeldt C., Bartsch R. The new anticonvulsant D-23129 acts as a potent potassium channel opener in neuronal cells. Naunyn-Schmiedenbergs Arch. Pharmacol. 353 (Suppl.):1996;R97.
24. Rundfeldt C., Tober C., Ganquly A., Wolf H.H., White H.S. Potassium channel opening properties of D-23129, an anticonvulsant with potent effects in rodent models for generalized and focal seizures. Soc. Neurosci. Abstr. 21:1995;203.
25. Rundfeldt C., Rohlfs A., Netzer R. Multiple actions of the new anticonvulsant D-23129 on voltage-gated inward currents and GABA-induced currents in cultured neuronal cells. Naunyn-Schmiedebergs Arch. Pharmacol. 351 (Suppl.):1995;R160.
26. Rupersberg J.P., Ermler M., Knopf M., Kues W., Jonas P., Koenen M. Properties of shaker-homologues potassium channels expressed in the mammalian brain. Cell Physiol. Biochem. 3:1993;250-258.
27. Skeen G.A., Wolf H.H., White H.S. D-23129 attenuates glutamate-evoked whole-cell currents of mouse cortical neurons through an interaction with kainate-sensitive ion channels. Soc. Neurosci. Abstr. 21:1995;353.
28. Takumi T., Ohkubo H., Nakanishi S. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science. 242:1988;1042-1045.
29. Tober C., Rundfeldt C., Rostock A., Bartsch R., Nickel B., Szeleny I., Herbst M., Dieter R., Olbrich A., Kutscher B., Sauer W., Jainta H., Jahn W., Engel J. D-23129. Drugs Future. 20:1995;1112-1115.
30. Tober C., Rostock A., Rundfeldt C., Bartsch R. D-23129: A potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur. J. Pharmacol. 303:1996;163-169.
31. Yonekawa W.D., Kapetanovic I.M., Kupferberg H.J. The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro. Epilepsy Res. 20:1995;137-150.